AbbVie Inc., a biopharmaceutical company, is dedicated to researching, developing, and marketing both biopharmaceutical and small molecule drugs. AbbVie operates through a single business segment that includes a portfolio of pharmaceutical products.
AbbVie was incorporated on April 10, 2012, and is the result of a spin-off by Abbott Laboratories. It is currently headquartered in North Chicago, Illinois, United States.
AbbVie's product line includes a range of pharmaceuticals that target serious chronic conditions and encompass therapeutic areas such as immunology, oncology, neuroscience, virology, and general medicine.
|Mr. Richard A. Gonzalez||Chairman & CEO||6.95M||N/A||1954|
|Mr. Robert A. Michael||President & COO||4M||N/A||1970|
|Mr. Scott T. Reents||Executive VP & CFO||2.97M||N/A||1968|
|Dr. Azita Saleki-Gerhardt Ph.D.||Executive VP & COO||2.58M||N/A||1963|
|Mr. Jeffrey Ryan Stewart||Executive VP & Chief Commercial Officer||2.98M||2.78M||1969|
|Dr. Thomas J. Hudson M.D.||Senior VP of Research & Development and Chief Scientific Officer||N/A||N/A||1962|
|Ms. Elizabeth Shea||Senior Vice President of Investor Relations||N/A||N/A||N/A|
|Mr. Sanjay Narayan||VP, Chief Ethics & Compliance Officer||N/A||N/A||N/A|
|Ms. Tracie Haas||Senior Vice President of Corporate Responsibility, Brand & Communications||N/A||N/A||N/A|
|Mr. Timothy J. Richmond||Executive VP & Chief Human Resources Officer||1.12M||N/A||1966|